1593. Recurrence of Clostridium difficile Infection in Multiple Myeloma Patients Receiving Prophylactic Oral Vancomycin or Oral Metronidazole vs. No Prophylaxis

por Moran, Gisele, Yarlagadda, Naveen, Susanibar, Sandra, Kothari, Atul, Rico, Juan Carlos, Burgess, Mary J
Publicado 2018

Mechanisms of resistance to BRAF and MEK inhibitors and clinical update of US Food and Drug Administration-approved targeted therapy in advanced melanoma

por Kakadia, Sunilkumar, Yarlagadda, Naveen, Awad, Ramez, Kundranda, Madappa, Niu, Jiaxin, Naraev, Boris, Mina, Lida, Dragovich, Tomislav, Gimbel, Mark, Mahmoud, Fade
Publicado 2018

Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma

por Mohan, Meera, Kendrick, Samantha, Szabo, Aniko, Yarlagadda, Naveen, Atwal, Dinesh, Pandey, Yadav, Roy, Arya, Parikh, Richa, Lopez, James, Thanendrarajan, Sharmilan, Schinke, Carolina, Alapat, Daisy, Sawyer, Jeffrey, Tian, Erming, Tricot, Guido, van Rhee, Frits, Zangari, Maurizio
Publicado 2022

Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns

por Schinke, Carolina, Boyle, Eileen M., Ashby, Cody, Wang, Yan, Lyzogubov, Valeriy, Wardell, Christopher, Qu, Pingping, Hoering, Antje, Deshpande, Shayu, Ryan, Katie, Thanendrarajan, Sharmilan, Mohan, Meera, Yarlagadda, Naveen, Khan, Maliha, Choudhury, Samrat Roy, Zangari, Maurizio, van Rhee, Frits, Davies, Faith, Barlogie, Bart, Morgan, Gareth, Walker, Brian A.
Publicado 2020